4.04 USD
▲-0.01+1.76%
盘后 3.96 -0.25%
2026-08-03
市值
$188.22M
市盈率
—
EPS
-23.66
股息率
—
52 周区间
1.76 – 12.46
成交量
84.93K
Beta
-0.18
目标价
9.50
52W 低 1.7652W 高 12.46
价格走势
公司简介
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.